Igcine ukubuyekezwa ngoSepthemba 8, 2022 ngo-09:16 am
Uhlu lwe-Top Swiss Based Izinkampani Zemithi ahlelwa ngokusekelwe emalini engenayo isiyonke yonyaka wakamuva. I-Roche inkulu kakhulu Inkampani Yezokwelapha eSwitzerland ngeNgeniso ka-$66 Billion ngonyaka odlule kulandele uNovartis noVifor.
I-Roche - Enkulu Inkampani ye-Pharma e-Swiss: Kuwo wonke umlando weminyaka eyi-125, i-Roche ikhule yaba enye yezinkampani ezinkulu kakhulu ze-biotech emhlabeni, kanye nomhlinzeki oholayo we-in-vitro diagnostics kanye nomnikezeli womhlaba wonke wezixazululo ezishintshayo ezishintshayo kuzo zonke izindawo zezifo ezinkulu.
Uhlu lwezinkampani eziphezulu ze-Swiss Based Pharmaceutical Companies
Ngakho-ke nalu Uhlu Lwama-Top Swiss Based Pharmaceutical Izinkampani ngokuthengiswa okuphelele (Imali engenayo).
| S.NO | Incazelo | Imali engenayo | Abasebenzi | I-Debt-to-Equity Ratio | Buyela ku-Equity | Uphawu Lwesitoko |
| 1 | ROCK | $65,980 million | 101465 | 0.4 | 40.4 | RO |
| 2 | I-NOVARTIS | $51,668 million | 105794 | 0.6 | 17.3 | NOVN |
| 3 | I-VIFOR | $1,930 million | 2600 | 0.2 | 5.9 | I-VIFN |
| 4 | SIEGFRIED | $956 million | 2500 | 0.9 | 13.9 | SFZN |
| 5 | I-BACHEM | $455 million | 1529 | 0.3 | 21.3 | BANB |
| 6 | BASILEA | $144 million | 150 | -2.9 | BSLN | |
| 7 | I-IDORSIA | $81 million | 5.5 | -237.9 | I-IDIA | |
| 8 | Inkampani COSMO PHARM | $74 million | 265 | 0.5 | -2.8 | COPN |
| 9 | SANTHERA | $17 million | 91 | 5.2 | -1316.2 | SAN |
| 10 | SPEXIS N | $16 million | 52 | -1.6 | -347.9 | I-SPEX |
| 11 | EVOLVA N | $9 million | 65 | 0.1 | -29.1 | EVE |
| 12 | NEWRON PHARMA N | $6 million | 3.1 | -110.5 | NWRN | |
| 13 | I-ADDEX N | $4 million | 27 | 0.0 | -89.8 | I-ADXN |
I-Novartis - Inkampani yesibili ngobukhulu yaseSwitzerland Pharma
I-Novartis yasungulwa ngo-1996 ngokuhlanganiswa kwe-Ciba-Geigy ne-Sandoz. I-Novartis nezinkampani ezandulele ilandela izimpande emuva eminyakeni engaphezu kwengama-250, inomlando ocebile wokuthuthukisa imikhiqizo emisha.
I-Novartis icabanga kabusha umuthi wokuthuthukisa nokwandisa izimpilo zabantu. Njengenkampani yemithi ehamba phambili emhlabeni wonke, inkampani isebenzisa isayensi emisha nobuchwepheshe bedijithali ukudala ukwelapha okuguqukayo ezindaweni ezinesidingo esikhulu sezokwelapha. Emzamweni wethu wokuthola imithi emisha, inkampani ihlezi ikleliswa phakathi kweyomhlaba izinkampani eziphezulu ukutshala imali ocwaningweni nasekuthuthukisweni.
Imikhiqizo ye-Novartis ifinyelela cishe abantu abayizigidi ezingu-800 emhlabeni jikelele futhi sithola izindlela ezintsha zokwandisa ukufinyelela ekwelapheni kwethu kwakamuva. Cishe abantu abayi-110,000 bezizwe ezingaphezu kuka-140 basebenza eNovartis emhlabeni jikelele.
I-Vifor Pharma
I-Vifor Pharma Group yinkampani yomhlaba wonke yemithi. Ihlose ukuba umholi womhlaba wonke ekuntulekeni kwe-iron kanye ne-nephrology ngokugxila ezifweni ezingavamile. Le nkampani inguzakwethu oyikhethayo kwezemithi kanye nezixazululo ezintsha ezigxile esigulini.
I-Vifor Pharma Group ilwela ukusiza iziguli emhlabeni wonke ezinezifo ezinzima nezingamahlalakhona ziphile impilo engcono, enempilo.
I-Bachem
I-Bachem yasungulwa ngo-1971 ngu-Peter Grogg njengo-Bachem Feinchemikalien AG enabasebenzi ababili e-Liestal eduze kwase-Basel egxile ekuhlanganiseni kwe-peptide. Ngo-1977, uBachem wathuthela eBubendorf nabasebenzi abayisishiyagalombili kwathi ngo-1978 wakhiqiza ama-peptide ukuze asetshenziswe kwezokwelapha ngaphansi kwemihlahlandlela ye-GMP okokuqala ngqa. Phakathi kuka-1981 no-1991, i-Bachem yaphinda kathathu umthamo wayo wokukhiqiza, kuyilapho isibalo sabasebenzi sakhula saba ngu-150. Ngo-1995, izikhungo, kuhlanganise nomnyango wokulawula izinga, zanwetshwa zaba yi-168,000 sq. ft. (15,600 m2). Isibalo sabasebenzi sikhule safinyelela ku-190.
Ukunwetshwa kwezimakethe ezingezona ezaseYurophu kwaqala ngokusungulwa kwe-Bachem Bioscience, Inc. e-Philadelphia, e-USA, ngo-1987. Ukuze kuqiniswe ubukhona bayo eYurophu, i-Bachem yavula izikhungo zokuthengisa nezokuthengisa eJalimane ngo-1988 futhi France ngo-1993. Ngo-1996, yathola umkhiqizi wesibili ngobukhulu wama-peptides, i-Bachem California eTorrance, e-USA, kanye nezinkampani ezingaphansi kwayo eJalimane nase-UK.
I-Bachem izovela esidlangalaleni ngoJuni 18, 1998. Amasheya afakwe ohlwini lweSwiss Stock Exchange. Iqembu lizuze ukuthengiswa kwe-CHF eyizigidi ezingama-96 futhi laqasha abantu abangama-331 emhlabeni jikelele. Ngo-1999, i-Bachem ithola i-Peninsula Laboratories, Inc., ezinze e-San Carlos, e-California, kanye nenkampani engaphansi kwayo e-England, ehlanganiswe ne-Bachem UK - yona uqobo ekuqaleni eyayiyingxenye ye-California-based Bachem Inc. ngo-2000.
Ukutholwa kwe-Sochinaz SA, umkhiqizi okhethekile ozinze eSwitzerland (Vionnaz) wezithako zemithi esebenzayo ngo-2001, kwaqinisa ubuchwepheshe be-Bachem futhi kwaphinde kwanweba amandla ayo okukhiqiza. Isibalo esiphezulu seQembu sikhule ngalesi sikhathi safinyelela kubasebenzi abangama-500 futhi ukuthengiswa kwafinyelela ku-141,4 million CHF.
Ngakho-ke ekugcineni lolu Uhlu Lwezinkampani Eziphezulu Zemithi Ye-Swiss Based Pharmaceutical ngokusekelwe ekuthengisweni onyakeni wakamuva.
Funda kabanzi mayelana no Izinkampani eziphezulu ze-Pharma eNdiya.
